Pharmaceutical and Biotech Leaders from Across the Globe Will Gather Once Again This October in Munich
By bringing the collective knowledge and practical experiences of leading in-house IP counsel, patent prosecutors and litigators, the EPO, Munich Patent Court, and policy experts from around the world, C5’s 2022 Life Sciences Patent Summit + Global SPC Review will provide you with comprehensive knowledge and benchmarking opportunities to ensure that you are leading the way in patent protection for your company and clients.
A MUST ATTEND EVENT FOR
Representatives from corporate organisations from functions including:
- Patent Counsel
- Head of IP
- VP-Intellectual Property
- Scientific Director
- Senior IP Counsel
- Associate General Counsel IP
- European Patent Attorney
- Head of Legal Affairs
- Principal Patent Examiner
- Vice President & Chief Counsel – IP
- VP Head Group Intellectual Property
- Head of Global Strategy
- Direct of Patent and Design Rights
- CTO
- Product Manager
- Director Innovation, IP and Portfolio Management
- Director IP Strategy & Projects
- R&D Patent Manager
- Technology Development Manager
- Associate VP & Director of Technology Licensing & Commercialization
Legal Practitioners
- Intellectual Property and Patent
- Life Sciences
- European Patent
- US Patent
Testimonials
Another great C5 conference. Good variety of attendees and topics.
Good meeting; I enjoyed it a lot, including both the talks and the social side.
Again, very good speakers from all over Europe and the US.
PAST ATTENDING COMPANIES
- Ablynx NV
- Alkermes Pharma Ireland Ltd
- AstraZeneca AB
- Benitec Biopharma Limited
- Biotronik
- Boehringer Ingelheim
- Celltrion
- Chiesi Farmaceutici Spa
- EGIS Pharmaceuticals PLC
- Esteve Group
- European Patent Office
- F. Hoffmann-La Roche Ltd
- Federal Agency for Nature
- Finnish Patent and Registration Office
- Fresenius Medical Care AG & Co
- Fresenius Medical Care AG & Co. KG Aa
- Geistlich Pharma AG
- Genmab AS
- German Patent & Trade Mark Office
- GlaxoSmithKline
- Groupe Sanofi
- Helsinn Healthcare SA
- JETRO Duesseldorf
- Leukocare AG
- Linde Healthcare
- Merus NV
- Novartis Pharma AG
- Novo Nordisk A/S
- PARI Pharma GmbH
- Patent Office Denmark
- Patents Office Ireland
- Sandoz International GmbH
- Sanofi-Aventis Deutschland GmbH
- Silence Therapeutics Plc
- Swiss Federal Institute of Intellectual Property
- Teva Pharmaceuticals Ltd
- TiGenix NV
- UCB Chong Kun Dang pharm.
- Valea AB
- Zacco Denmark AS
- Zealand Pharma AS
- Zentiva Group
GLOBAL SERIES OF LIFE SCIENCES
Related Conferences
